autologous v allogeneic, page-21

Medipost. South Korean company. Has had a stem cell based product on sale since 2012, from memory.

Of course, Osiris got approval in Canada and NZ, though it doesn't look as if any has been sold, before or subsequent toMSB's purchase of the asset.

And why are my comments distracting from "the substance of discussion"? You made some assertions about when revenue from the US would occur. I provided an alternate point of view, based upon analysis and experience.

I think, Dolcevita, that you are the one who is misleading people, with unrealistic predictions of launch timing. In fact, from your own reports on the AGM, it seems that Silviu was reticent to put a likely timeline on US launch. Not so, his cheerleader-in chief.